AMARYL

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Singapore, Turkey, United States, South Africa

Active ingredients

The drug AMARYL contains one active pharmaceutical ingredient (API):

1 Glimepiride
UNII 6KY687524K - GLIMEPIRIDE

Glimepiride is an orally active hypoglycaemic substance belonging to the sulphonylurea group. It may be used in non-insulin dependent (type 2) diabetes mellitus. Glimepiride acts mainly by stimulating insulin release from pancreatic beta cells.

Read about Glimepiride

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
AMARYL Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A10BB12 Glimepiride A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives
Discover more medicines within A10BB12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 8450R, 8451T, 8452W, 8533D
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 502800603115314, 576720060073617, 576720060073717, 576720060073817, 576720060073917, 576720060074017, 576720060074117, 576720060074217, 576720060074317
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 00367752, 00782675, 02751845, 03215310, 03500430, 03897522, 04102565, 04711459, 04748899, 09262196, 09262204, 09262233, 09262256, 09262345, 09262351, 09262374, 09262397, 09284513
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 26.503-07-05, 26.504-07-05
Country: EE Ravimiamet Identifier(s): 1084957, 1084968, 1084979, 1084980, 1110328, 1110339, 1125391, 1125403, 1395121, 1395132, 1429523, 1429534, 1429545, 1429556, 1429567, 1429578, 1429589, 1429590, 1429602, 1429613, 1429624, 1429635, 1429646, 1429657, 1429668, 1429679, 1429680, 1429691, 1429703, 1429714, 1429725, 1429736, 1429747, 1429758, 1429769, 1429770, 1429781, 1429792, 1429804, 1429815, 1429826, 1429837, 1429848, 1429859, 1429860, 1429871, 1429882, 1429893, 1429905, 1429916, 1433270, 1542765, 1542787, 1542798, 1542800, 1542811, 1670981, 1670992, 1671016, 1671027, 1671038, 1671049, 1671050, 1671061, 1671072, 1671083, 1671117, 1671128, 1671139, 1671140, 1671151, 1671162, 1671173, 1671184, 1671195, 1671207, 1846942, 1846997, 1847011, 1847033, 1847044, 1847055, 1847066, 1847077, 1847088, 1848405
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 61406, 61409
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 004586, 091751, 091769, 097881
Country: HK Department of Health Drug Office Identifier(s): 42323, 42325
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-836629436, HR-H-851734879
Country: IE Health Products Regulatory Authority Identifier(s): 12576, 12706, 12713, 12738, 12916
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4390, 4391, 4392, 6385
Country: IT Agenzia del Farmaco Identifier(s): 032845012, 032845164, 032845226
Country: JP 医薬品医療機器総合機構 Identifier(s): 3961008F1020, 3961008F2027, 3961008F3023
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1003243, 1003748, 1003774, 1003775, 1050505, 1050506, 1050507, 1050508, 1050509, 1050510, 1050511, 1050512, 1050513, 1050514, 1050515, 1050516, 1050517, 1050518, 1050519, 1050520, 1050521, 1050522, 1050523, 1050524, 1050525, 1050526, 1050527, 1050528, 1050529, 1050530, 1050531, 1050532, 1050533, 1050534, 1050535, 1050536, 1050537, 1050538, 1050539, 1050540, 1052221, 1063343, 1063344, 1063345, 1063346, 1066052, 1072788, 1072789, 1072790, 1075583, 1075584, 1081253, 1081254
Country: MT Medicines Authority Identifier(s): AA1438/00501, AA1438/00502, AA1438/00503, AA1438/00504, AA908/09809, AA908/09810, AA908/09811, AA908/09812
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 466M97
Country: NL Z-Index G-Standaard, PRK Identifier(s): 44423, 44431, 44458, 44466
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100078329, 100078335, 100078341, 100078358, 100240681, 100464083
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W62433001, W62433002, W62433003, W62433004, W62433005, W62433006, W62433007, W62433008, W62433009, W62433010, W62433011, W62433012, W62434001, W62434002, W62434003, W62434004, W62434005, W62434006, W62434007, W62434008, W62434009, W62434010, W62434011, W62435001, W62435002, W62435003, W62435004, W62435005, W62435006, W62435007, W62435008, W62435009, W62435010, W62435011, W62436001, W62436002, W62436003, W62436004, W62436005, W62436006, W62436007, W62436008, W62436009, W62436010, W62436011, W62437001, W62437002, W62437003, W62437004, W62437005, W62437006, W62437007, W62437008, W62437009, W62437010, W62437011
Country: SG Health Sciences Authority Identifier(s): 10459P, 10460P, 10462P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699809010208, 8699809010215, 8699809010222, 8699809010239, 8699809018358, 8699809018372
Country: US FDA, National Drug Code Identifier(s): 0039-0221, 0039-0222, 0039-0223
Country: ZA Health Products Regulatory Authority Identifier(s): 30/21.2/0060, 30/21.2/0061, 30/21.2/0063

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.